Funding for this research was provided by:
Cancer Institute NSW (15/ECF/1-38)
Cancer Council NSW (RG 19-04, RG10-04, RG08-16)
National Health and Medical Research Council (1010303)
Received: 30 May 2019
Accepted: 14 August 2019
First Online: 28 August 2019
Ethics approval and consent to participate
: This study was approved by the Macquarie University Human Research Ethics Committee (MQ HREC approval #5201200702). All plasma samples were collected through the Victorian Cancer Biobank with written consent.
: The cohort of EDTA-plasma samples was procured from the Victorian Cancer Biobank (VCB) in Melbourne, Australia. The VCB obtained written informed consent from all study participants for biospecimen collection and research use. The VCB and participating healthcare institutions comply with all existing Australian federal, state, territory and institutional requirements pertaining to the participation of patients in research as well as the collection and use of research biospecimens (including publication) and accompanying clinical data.
: The authors declare that they have no competing interests.